1992
DOI: 10.1203/00006450-199203000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Decreased Granulocyte-Macrophage Colony-Stimulating Factor Production by Human Neonatal Blood Mononuclear Cells and T Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
15
0
1

Year Published

1992
1992
2005
2005

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(18 citation statements)
references
References 39 publications
2
15
0
1
Order By: Relevance
“…Earlier studies demonstrated that monocytes of healthy full-term neonates possess intact phagocytic capacity and oxidative burst against C. albicans [39,40], although their activation by IFN-Á has been found defective [12] along with other defective functions such as cytokine production, capability of rapid activation, and expression of surface antigens as well as adherence molecules [41][42][43][44]. Our initial findings are consistent with these data.…”
Section: Discussionsupporting
confidence: 82%
“…Earlier studies demonstrated that monocytes of healthy full-term neonates possess intact phagocytic capacity and oxidative burst against C. albicans [39,40], although their activation by IFN-Á has been found defective [12] along with other defective functions such as cytokine production, capability of rapid activation, and expression of surface antigens as well as adherence molecules [41][42][43][44]. Our initial findings are consistent with these data.…”
Section: Discussionsupporting
confidence: 82%
“…Foetal and neonatal MPC appear competent with respect to phagocytic activity and bacterial killing, but exhibit diminished capacity for expression of a variety of pro-inflammatory functions including production of effecter cytokines, such as IL-6 [19] and tumour necrosis factor-a [20], which may account in part for the diminished febrile response of neonates.…”
Section: Innate Immune Functions In Foetal and Neonatal Lifementioning
confidence: 99%
“…20,21,30,39,40 The basal concentrations of GM-CSF in neonatal sera are negligible, and decreased GM-CSF expression and production may contribute to the development of neutropenia. 13,14 In a recent clinical trial, administration of recombinant human GM-CSF to premature infants was well-tolerated, and peripheral blood PMN counts and CR3 receptor expression were significantly increased. 30 Although GM-CSF may increase N-PMN count and function, type III GBS is most efficiently killed by PMNs when opsonized with complement and capsular polysaccharide-specific Ab.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the previously demonstrated priming for oxidative metabolism that occurs with GM-CSF treatment may have contributed to the enhanced microbial killing observed. 19 Although the production of GM-CSF by neonatal mononuclear cells may be reduced, [12][13][14] it also has been shown that the bactericidal activity of N-PMNs can be increased by GM-CSF. 19 Deficiencies in neonatal host defenses contribute to susceptibility to GBS infections.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation